The utility of in vitro models of traumatic brain injury (TBI) depends on their ability to recapitulate the in vivo TBI cascade. In this study, we used a genome-wide approach to compare changes in gene expression at several time points post-injury in both an in vitro model and an in vivo model of TBI. We found a total of 2073 differentially expressed genes in our in vitro model and 877 differentially expressed genes in our in vivo model when compared to noninjured controls. We found a strong correlation in gene expression changes between the two models (r = 0.69), providing confidence that the in vitro model represented at least part of the in vivo injury cascade. From these data, we searched for genes with significant changes in expression over time (analysis of covariance) and identified sorting protein-related receptor with A-type repeats (SORLA). SORLA directs amyloid precursor protein to the recycling pathway by direct binding and away from amyloid-beta producing enzymes. Mutations of SORLA have been linked to Alzheimer's disease (AD). We confirmed downregulation of SORLA expression in organotypic hippocampal slice cultures by immunohistochemistry and Western blotting and present preliminary data from human tissue that is consistent with these experimental results. Together, these data suggest that the in vitro model of TBI used in this study strongly recapitulates the in vivo TBI pathobiology and is well suited for future mechanistic or therapeutic studies. The data also suggest the possible involvement of SORLA in the post-traumatic cascade linking TBI to AD.
WillisC., LybrandS., and BellamyN. (2004). Excitatory amino acid inhibitors for traumatic brain injury. Cochrane Database Syst. Rev., CD003986.
5.
TausskyP., TawkR.G., DaughertyW.P., and HanelR.A. (2011). Medical therapy for ischemic stroke: review of intravenous and intra-arterial treatment options. World. Neurosurg., 76, 6 Suppl., S9–S15.
6.
KelleyR.E., and Martin-SchildS. (2012). Ischemic stroke: emergencies and management. Neurol. Clin., 30, 187–210, ix.
7.
BaughC.M., RobbinsC.A., SternR.A., and McKeeA.C. (2014). Current understanding of chronic traumatic encephalopathy. Curr. Treat. Options Neurol., 16, 306.
8.
GavettB.E., SternR.A., and McKeeA.C. (2011). Chronic traumatic encephalopathy: a potential late effect of sport-related concussive and subconcussive head trauma. Clin. Sports Med., 30, 179–188, xi.
9.
MorettiL., CristoforiI., WeaverS.M., ChauA., PortelliJ.N., and GrafmanJ. (2012). Cognitive decline in older adults with a history of traumatic brain injury. Lancet Neurol. 11, 1103–1112.
10.
StoicaB.A., and FadenA.I. (2010). Cell death mechanisms and modulation in traumatic brain injury. Neurotherapeutics, 7, 3–12.
11.
GoldE.M., SuD., Lopez-VelazquezL., HausD.L., PerezH., LacuestaG.A., AndersonA.J., and CummingsB.J. (2013). Functional assessment of long-term deficits in rodent models of traumatic brain injury. Regen. Med., 8, 483–516.
12.
MorrisonB.III, ElkinB.S., DolleJ.P., and YarmushM.L. (2011). In vitro models of traumatic brain injury. Annu. Rev. Biomed. Eng., 13, 91–126.
13.
FodorS.P., RavaR.P., HuangX.C., PeaseA.C., HolmesC.P., and AdamsC.L. (1993). Multiplexed biochemical assays with biological chips. Nature, 364, 555–556.
14.
MorrisonB.III, EberwineJ.H., MeaneyD.F., and McIntoshT.K. (2000). Traumatic injury induces differential expression of cell death genes in organotypic brain slice cultures determined by complementary DNA array hybridization. Neuroscience, 96, 131–139.
15.
PoulsenC.B., PenkowaM., BorupR., NielsenF.C., CaceresM., QuintanaA., MolineroA., CarrascoJ., GiraltM., and HidalgoJ. (2005). Brain response to traumatic brain injury in wild-type and interleukin-6 knockout mice: a microarray analysis. J. Neurochem., 92, 417–432.
16.
Di PietroV., AminD., PernagalloS., LazzarinoG., TavazziB., VagnozziR., PringleA., and BelliA. (2010). Transcriptomics of traumatic brain injury: gene expression and molecular pathways of different grades of insult in a rat organotypic hippocampal culture model. J. Neurotrauma, 27, 349–359.
17.
HazenS.P., BorevitzJ.O., HarmonF.G., Pruneda-PazJ.L., SchultzT.F., YanovskyM.J., LiljegrenS.J., EckerJ.R., and KayS.A. (2005). Rapid array mapping of circadian clock and developmental mutations in Arabidopsis. Plant Physiol. 138, 990–997.
18.
MengerG.J., LuK., ThomasT., CassoneV.M., and EarnestD.J. (2005). Circadian profiling of the transcriptome in immortalized rat SCN cells. Physiol. Genomics, 21, 370–381.
19.
AryeeM.J., Gutierrez-PabelloJ.A., KramnikI., MaitiT., and QuackenbushJ. (2009). An improved empirical bayes approach to estimating differential gene expression in microarray time-course data: BETR (Bayesian Estimation of Temporal Regulation). BMC Bioinformatics, 10, 409.
20.
LeekJ.T., MonsenE., DabneyA.R., and StoreyJ.D. (2006). EDGE: extraction and analysis of differential gene expression. Bioinformatics, 22, 507–508.
21.
ElkinB.S., andMorrisonB.III. (2007). Region-specific tolerance criteria for the living brain. Stapp Car Crash J. 51, 127–138.
22.
YuZ., TsayC., LacourS.P., WagnerS., and MorrisonB. (2006). Stretchable microelectrode arrays a tool for discovering mechanisms of functional deficits underlying traumatic brain injury and interfacing neurons with neuroprosthetics. Conf. Proc. IEEE Eng. Med. Biol. Soc., 1Suppl., 6732–6735.
23.
CaterH.L., GittermanD., DavisS.M., BenhamC.D., MorrisonB.III, and SundstromL.E. (2007). Stretch-induced injury in organotypic hippocampal slice cultures reproduces in vivo post-traumatic neurodegeneration: role of glutamate receptors and voltage-dependent calcium channels. J. Neurochem., 101, 434–447.
24.
MorrisonB.III, MeaneyD.F., MarguliesS.S. and McIntoshT.K. (2000). Dynamic mechanical stretch of organotypic brain slice cultures induces differential genomic expression: relationship to mechanical parameters. J. Biomech. Eng., 122, 224–230.
25.
DiLeonardiA.M., HuhJ.W., and RaghupathiR. (2009). Impaired axonal transport and neurofilament compaction occur in separate populations of injured axons following diffuse brain injury in the immature rat. Brain Res. 1263, 174–182.
26.
HuhJ.W., WidingA.G., and RaghupathiR. (2008). Midline brain injury in the immature rat induces sustained cognitive deficits, bihemispheric axonal injury and neurodegeneration. Exp. Neurol., 213, 84–92.
27.
RaghupathiR., and HuhJ.W. (2007). Diffuse brain injury in the immature rat: evidence for an age-at-injury effect on cognitive function and histopathologic damage. J. Neurotrauma, 24, 1596–1608.
28.
Buggia-PrévotV., and ThinakaranG. (2014). Sorting the role of SORLA in Alzheimer's disease. Sci Transl Med, 6, 223fs228.
29.
CaglayanS., Takagi-NiidomeS., LiaoF., CarloA.S., SchmidtV., BurgertT., KitagoY., FuchtbauerE.M., FuchtbauerA., HoltzmanD.M., TakagiJ., and WillnowT.E. (2014). Lysosomal sorting of amyloid-beta by the SORLA receptor is impaired by a familial Alzheimer's disease mutation. Sci. Transl. Med., 6, 223ra220.
30.
StoppiniL., BuchsP.A. and MullerD. (1991). A simple method for organotypic cultures of nervous tissue. J. Neurosci. Methods, 37, 173–182.
31.
MorrisonB., PringleA.K., McManusT., EllardJ., BradleyM., SignorelliF., IannottiF., and SundstromL.E. (2002). L-Arginyl-3,4-Spermidine is neuroprotective in several in vitro models of neurodegeneration and in vivo ischaemia without suppressing synaptic transmission. Brit. J. Pharmacol., 137, 1255–1268.
32.
SundstromL., MorrisonB., BradleyM. and PringleA. (2005). Organotypic cultures as tools for functional screening in the CNS. Drug Discov Today, 10, 993–1000.
33.
IrizarryR.A., HobbsB., CollinF., Beazer-BarclayY.D., AntonellisK.J., ScherfU. and SpeedT.P. (2003). Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics, 4, 249–264.
34.
StoreyJ.D. and TibshiraniR. (2003). Statistical significance for genomewide studies. Proc Natl Acad Sci U S A, 100, 9440–9445.
35.
BrettschneiderJ., CollinF., BolstadB.M. and SpeedT.P. (2008). Quality assessment for short oligonucleotide microarray data. Technometrics, 50, 241–264.
36.
Huang daW., ShermanB.T. and LempickiR.A. (2009). Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc, 4, 44–57.
37.
SchneiderC.A., RasbandW.S. and EliceiriK.W. (2012). NIH Image to ImageJ: 25 years of image analysis. Nat Methods, 9, 671–675.
38.
MotoiY., AizawaT., HagaS., NakamuraS., NambaY., and IkedaK. (1999). Neuronal localization of a novel mosaic apolipoprotein E receptor, LR11, in rat and human brain. Brain Res. 833, 209–215.
39.
MarguliesS., and HicksR. (2009). Combination therapies for traumatic brain injury: prospective considerations. J. Neurotrauma, 26, 925–939.
40.
MarguliesS., AndersonG., AtifF., BadautJ., ClarkR., EmpeyP., GusevaM., HoaneM., HuhJ., PaulyJ., RaghupathiR., ScheffS., SteinD., TangH., and HicksM. (2016). Combination therapies for traumatic brain injury: retrospective considerations. J. Neurotrauma, 33, 101–112.
41.
WhiteT.E., FordG.D., Surles-ZeiglerM.C., GatesA.S., LaplacaM.C., and FordB.D. (2013). Gene expression patterns following unilateral traumatic brain injury reveals a local pro-inflammatory and remote anti-inflammatory response. BMC Genomics, 14, 282.
42.
IshikawaY., UchinoH., MorotaS., LiC., TakahashiT., IkedaY., IshiiN., and ShibasakiF. (2006). Search for novel gene markers of traumatic brain injury by time differential microarray analysis. Acta Neurochir. Suppl., 96, 163–167.
43.
Di PietroV., AmoriniA.M., TavazziB., HovdaD.A., SignorettiS., GizaC.C., LazzarinoG., VagnozziR., and BelliA. (2013). Potentially neuroprotective gene modulation in an in vitro model of mild traumatic brain injury. Mol. Cell. Biochem., 375, 185–198.
44.
BarrT.L., AlexanderS., and ConleyY. (2011). Gene expression profiling for discovery of novel targets in human traumatic brain injury. Biol. Res. Nurs., 13, 140–153.
45.
MatzilevichD.A., RallJ.M., MooreA.N., GrillR.J., and DashP.K. (2002). High-density microarray analysis of hippocampal gene expression following experimental brain injury. J. Neurosci. Res., 67, 646–663.
46.
StraussK.I., BarbeM.F., MarshallR.M., RaghupathiR., MehtaS., and NarayanR.K. (2000). Prolonged cyclooxygenase-2 induction in neurons and glia following traumatic brain injury in the rat. J. Neurotrauma, 17, 695–711.
47.
StraussK.I. (2008). Antiinflammatory and neuroprotective actions of COX2 inhibitors in the injured brain. Brain Behav. Immun., 22, 285–298.
48.
CrackP.J., GouldJ., ByeN., RossS., AliU., HabgoodM.D., Morganti-KossmanC., SaundersN.R., and HertzogP.J. (2009). The genomic profile of the cerebral cortex after closed head injury in mice: effects of minocycline. J. Neural Transm., 116, 1–12.
DutcherS.A., UnderwoodB.D., WalkerP.D., DiazF.G., and MichaelD.B. (1999). Patterns of immediate early gene mRNA expression following rodent and human traumatic brain injury. Neurol. Res., 21, 234–242.
51.
HayesR.L., YangK., RaghupathiR., and McIntoshT.K. (1995). Changes in gene expression following traumatic brain injury in the rat. J. Neurotrauma, 12, 779–790.
52.
RaghupathiR., and McIntoshT.K. (1996). Regionally and temporally distinct patterns of induction of c-fos, c-jun and junB mRNAs following experimental brain injury in the rat. Brain Res. Mol. brain Res., 37, 134–144.
53.
SempleB.D., ByeN., RancanM., ZiebellJ.M., and Morganti-KossmannM.C. (2010). Role of CCL2 (MCP-1) in traumatic brain injury (TBI): evidence from severe TBI patients and CCL2-/- mice. J. Cereb. Blood Flow Metab., 30, 769–782.
54.
MitchellJ.A., AkarasereenontP., ThiemermannC., FlowerR.J., and VaneJ.R. (1993). Selectivity of nonsteroidal antiinflammatory drugs as inhibitors of constitutive and inducible cyclooxygenase. Proc. Natl. Acad. Sci. U. S. A., 90, 11693–11697.
55.
EngelhardtG. (1996). Pharmacology of meloxicam, a new non-steroidal anti-inflammatory drug with an improved safety profile through preferential inhibition of COX-2. Br. J. Rheumatol., 35, Suppl. 1, 4–12.
56.
ChenX.K., XiongY.F., and ZhouZ. (2006). “Kiss-and-run” exocytosis in astrocytes. Neuroscientist, 12, 375–378.
57.
SauaiaA., MooreF.A., MooreE.E., MoserK.S., BrennanR., ReadR.A., and PonsP.T. (1995). Epidemiology of trauma deaths: a reassessment. J. Trauma, 38, 185–193.
DingJ.Y., KreipkeC.W., SchaferP., SchaferS., SpeirsS.L., and RafolsJ.A. (2009). Synapse loss regulated by matrix metalloproteinases in traumatic brain injury is associated with hypoxia inducible factor-1alpha expression. Brain Res. 1268, 125–134.
60.
FernandesK.A., HarderJ.M., FornarolaL.B., FreemanR.S., ClarkA.F., PangI.H., JohnS.W., and LibbyR.T. (2012). JNK2 and JNK3 are major regulators of axonal injury-induced retinal ganglion cell death. Neurobiol. Dis., 46, 393–401.
61.
KangW.H., SimonM.J., GaoS., BantaS., andMorrisonB.III. (2011). Attenuation of astrocyte activation by TAT-mediated delivery of a peptide JNK inhibitor. J. Neurotrauma, 28, 1219–1228.
62.
RiesV., SilvaR.M., OoT.F., ChengH.C., RzhetskayaM., KholodilovN., FlavellR.A., KuanC.Y., RakicP., and BurkeR.E. (2008). JNK2 and JNK3 combined are essential for apoptosis in dopamine neurons of the substantia nigra, but are not required for axon degeneration. J. Neurochem., 107, 1578–1588.
63.
TranH.T., SanchezL., and BrodyD.L. (2012). Inhibition of JNK by a peptide inhibitor reduces traumatic brain injury-induced tauopathy in transgenic mice. J. Neuropathol. Exp. Neurol., 71, 116–129.
64.
GreerJ.E., McGinnM.J., and PovlishockJ.T. (2011). Diffuse traumatic axonal injury in the mouse induces atrophy, c-Jun activation, and axonal outgrowth in the axotomized neuronal population. J. Neurosci., 31, 5089–5105.
65.
Beni-AdaniL., GozesI., CohenY., AssafY., SteingartR.A., BrennemanD.E., EizenbergO., TrembolverV., and ShohamiE. (2001). A peptide derived from activity-dependent neuroprotective protein (ADNP) ameliorates injury response in closed head injury in mice. J. Pharmacol. Exp. Ther., 296, 57–63.
66.
MandelS., RechaviG., and GozesI. (2007). Activity-dependent neuroprotective protein (ADNP) differentially interacts with chromatin to regulate genes essential for embryogenesis. Dev. Biol., 303, 814–824.
67.
UryuK., ChenX.H., MartinezD., BrowneK.D., JohnsonV.E., GrahamD.I., LeeV.M., TrojanowskiJ.Q., and SmithD.H. (2007). Multiple proteins implicated in neurodegenerative diseases accumulate in axons after brain trauma in humans. Exp. Neurol., 208, 185–192.
68.
KoizumiH., and PovlishockJ.T. (1998). Posttraumatic hypothermia in the treatment of axonal damage in an animal model of traumatic axonal injury. J. Neurosurg., 89, 303–309.
69.
StoneJ.R., OkonkwoD.O., SingletonR.H., MutluL.K., HelmG.A., and PovlishockJ.T. (2002). Caspase-3-mediated cleavage of amyloid precursor protein and formation of amyloid beta peptide in traumatic axonal injury. J. Neurotrauma, 19, 601–614.
70.
StoneJ.R., OkonkwoD.O., DialoA.O., RubinD.G., MutluL.K., PovlishockJ.T., and HelmG.A. (2004). Impaired axonal transport and altered axolemmal permeability occur in distinct populations of damaged axons following traumatic brain injury. Exp. Neurol., 190, 59–69.
71.
WashingtonP.M., MorffyN., ParsadanianM., ZappleD.N., and BurnsM.P. (2014). Experimental traumatic brain injury induces rapid aggregation and oligomerization of amyloid-beta in an Alzheimer's disease mouse model. J. Neurotrauma, 31, 125–134.
72.
MarklundN., FarrokhniaN., HanellA., VanmechelenE., EnbladP., ZetterbergH., BlennowK., and HilleredL. (2014). Monitoring of beta-amyloid dynamics after human traumatic brain injury. J. Neurotrauma, 31, 42–55.
73.
ChenX.H., SimanR., IwataA., MeaneyD.F., TrojanowskiJ.Q., and SmithD.H. (2004). Long-term accumulation of amyloid-beta, beta-secretase, presenilin-1, and caspase-3 in damaged axons following brain trauma. Am. J. Pathol., 165, 357–371.
74.
Van Den HeuvelC., ThorntonE., and VinkR. (2007). Traumatic brain injury and Alzheimer's disease: a review. Prog. Brain Res., 161, 303–316.
75.
ReifertJ., Hartung-CranstonD., and FeinsteinS.C. (2011). Amyloid beta-mediated cell death of cultured hippocampal neurons reveals extensive Tau fragmentation without increased full-length tau phosphorylation. J. Biol. Chem., 286, 20797–20811.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
